Fundraising Fox
Infinitopes
Oxford, GB · Founded 2021 · 30 employees on LinkedIn · 8 known investors
Find your way into Infinitopes
Sign up to see every warm intro you have to Infinitopes
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Infinitopes team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
Founders & leadership
Infinitopes was founded in 2021 by Jonathan Kwok and Lian Ni Lee.
Investors · 8
How we know: Amplify Partners's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Manta Ray Ventures's portfolio page · the company's own site · the Companies House shareholder list · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kindred Capital's portfolio page · the Companies House shareholder list · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the Companies House shareholder list · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- INFINITOPES LIMITED
- Company number
- 13642685
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 24 Sept 2021
- Registered office
- Bioescalator Innovation Building Oxford University, 696 Roosevelt Drive, Oxford, OX3 7FZ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 23 Sept 2025 · next due 7 Oct 2026
Current officers · 7
- Daniel Carey Cazel Hood — secretary, appointed 1 Jul 2025
- Joanna Elizabeth Brewer — director, appointed 1 Mar 2025
- Elliot Hershberg — director, appointed 19 Dec 2025
- Jonathan Kwok — director, appointed 24 Sept 2021
- Daniel Leonard Menichella — director, appointed 19 Mar 2025
- Hitesh Jayantilal Sanganee — director, appointed 5 Mar 2025
- Julia Schrameier — director, appointed 19 Dec 2025
Source: Companies House public register · retrieved 3 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Infinitopes do?
- Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
- Who founded Infinitopes?
- Infinitopes was founded by Jonathan Kwok, Lian Ni Lee in 2021.
- Who are Infinitopes's investors?
- Infinitopes's investors include Amplify Partners, Manta Ray Ventures, Octopus Ventures, EMV Capital, Kindred Capital, Martlet Capital, Nadav Rosenberg, Wilbe Capital.
- Where is Infinitopes headquartered?
- Infinitopes is headquartered in Oxford, GB.